Hbm Holdings Ownership
HK$9.85
2.43%
Hong Kong, Oct 29, 04:08 pm HKT.
Closed.
ISIN
KYG4403H1002
Symbol
2142
Industry
Hbm Holdings Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
AstraZeneca (UK) Ltd.
|
76.272m | 9.24% | — | Jan 31 2026 |
| 2 |
GIC Private Limited
|
71.954m | 8.72% | +8.979m | Jan 14 2026 |
| 3 |
Wang (Jingsong)
|
61.466m | 7.45% | — | Sep 05 2025 |
| 4 |
Legend Capital Ltd.
|
52.235m | 6.33% | -366.000k | Oct 06 2025 |
| 5 |
Advantech Capital LP
|
41.985m | 5.09% | -25.294m | Aug 15 2025 |
|
1
AstraZeneca (UK) Ltd.
|
9.24%
76.272m
|
|
2
GIC Private Limited
|
8.72%
71.954m
|
|
3
Wang (Jingsong)
|
7.45%
61.466m
|
|
4
Legend Capital Ltd.
|
6.33%
52.235m
|
|
5
Advantech Capital LP
|
5.09%
41.985m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 36.81% of Hbm Holdings, with AstraZeneca (UK) Ltd. the biggest at 9.24%, followed by GIC Private Limited (8.72%) and Wang (Jingsong) (7.45%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
